These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9689536)

  • 1. Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion-spheronization.
    Law MF; Deasy PB
    Eur J Pharm Biopharm; 1998 Jan; 45(1):57-65. PubMed ID: 9689536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two commercial brands of microcrystalline cellulose for extrusion-spheronization.
    Law MF; Deasy PB; McLaughlin JP; Gabriel S
    J Microencapsul; 1997; 14(6):713-23. PubMed ID: 9394252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization.
    Gouldson MP; Deasy PB
    J Microencapsul; 1997; 14(2):137-53. PubMed ID: 9132466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug.
    Zeeshan F; Peh KK; Tan YT
    AAPS PharmSciTech; 2009; 10(3):850-7. PubMed ID: 19554454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical properties of single pellets containing acrylic polymers.
    Wang CC; Zhang G; Shah NH; Infeld MH; Malick AW; McGinity JW
    Pharm Dev Technol; 1996 Jul; 1(2):213-22. PubMed ID: 9552348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Polymeric Excipients in the Stabilization of Olanzapine when Exposed to Aqueous Environments.
    Paisana M; Wahl M; Pinto J
    Molecules; 2015 Dec; 20(12):22364-82. PubMed ID: 26703534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight PE; Newton JM
    Int J Pharm; 2008 Feb; 350(1-2):145-54. PubMed ID: 17905548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
    Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
    Basit AW; Newton JM; Lacey LF
    Pharm Dev Technol; 1999; 4(4):499-505. PubMed ID: 10578503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization.
    Souto C; Rodríguez A; Parajes S; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):94-9. PubMed ID: 15967651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.